1. (1997) Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention. MMWR Recomm Rep 46:1–55
2. Stanek G, O’Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granstrom M, Guy E, Gray J (1996) European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 108:741–747
3. (1996) Practice parameter: Diagnosis of patients with nervous system Lyme borreliosis. Report of the Quality Standards Subcommittee of the American Academy of Neurology
4. Hansen K, Lebech AM (1991) Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi – specific immunoglobulin G, A, and M. Ann Neurol 30:197–205
5. Tumani H, Nolker G, Reiber H (1995) Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 45:1663–1670